MA49882A - Combinaison entre trifluridine/ chlorhydrate de tipiracil, complexe de platine anti-tumoral et modulateur de point de contrôle immunitaire - Google Patents

Combinaison entre trifluridine/ chlorhydrate de tipiracil, complexe de platine anti-tumoral et modulateur de point de contrôle immunitaire

Info

Publication number
MA49882A
MA49882A MA049882A MA49882A MA49882A MA 49882 A MA49882 A MA 49882A MA 049882 A MA049882 A MA 049882A MA 49882 A MA49882 A MA 49882A MA 49882 A MA49882 A MA 49882A
Authority
MA
Morocco
Prior art keywords
trifluridine
combination
immune checkpoint
platinum complex
checkpoint modulator
Prior art date
Application number
MA049882A
Other languages
English (en)
Inventor
Jean-Pierre Abastado
Nadia Amellal
Alain Bruno
Michaël Frank Burbridge
Valérie Cattan
Catherine Leger
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MA49882A publication Critical patent/MA49882A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MA049882A 2017-03-17 2018-03-16 Combinaison entre trifluridine/ chlorhydrate de tipiracil, complexe de platine anti-tumoral et modulateur de point de contrôle immunitaire MA49882A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17161630 2017-03-17

Publications (1)

Publication Number Publication Date
MA49882A true MA49882A (fr) 2020-06-24

Family

ID=58387699

Family Applications (1)

Application Number Title Priority Date Filing Date
MA049882A MA49882A (fr) 2017-03-17 2018-03-16 Combinaison entre trifluridine/ chlorhydrate de tipiracil, complexe de platine anti-tumoral et modulateur de point de contrôle immunitaire

Country Status (11)

Country Link
US (1) US20200009104A1 (fr)
EP (1) EP3595716A1 (fr)
JP (1) JP7168575B2 (fr)
CN (1) CN110402151A (fr)
AU (1) AU2018234141A1 (fr)
CA (1) CA3056485A1 (fr)
MA (1) MA49882A (fr)
MX (1) MX2019010937A (fr)
TW (1) TWI671072B (fr)
WO (1) WO2018167256A1 (fr)
ZA (1) ZA201905546B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11730753B2 (en) 2018-03-03 2023-08-22 Natco Pharma Limited Stable pharmaceutical compositions comprising trifluridine and tipiracil hydrochloride

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2191340C (fr) 1995-03-29 2001-04-17 Shingo Yano Derives d'uracile, agents de potentialisation d'effet antitumoral et agent antitumoral renfermant ces derives
PT3127544T (pt) * 2014-04-04 2021-11-08 Taiho Pharmaceutical Co Ltd Fármaco antitumoral que contém complexo de platina antitumoral e potenciador de efeito antitumoral

Also Published As

Publication number Publication date
RU2019131581A3 (fr) 2021-07-12
EP3595716A1 (fr) 2020-01-22
AU2018234141A1 (en) 2019-09-12
ZA201905546B (en) 2021-05-26
JP2020510058A (ja) 2020-04-02
CN110402151A (zh) 2019-11-01
TWI671072B (zh) 2019-09-11
WO2018167256A1 (fr) 2018-09-20
MX2019010937A (es) 2019-10-24
RU2019131581A (ru) 2021-04-19
TW201836616A (zh) 2018-10-16
CA3056485A1 (fr) 2018-09-20
JP7168575B2 (ja) 2022-11-09
US20200009104A1 (en) 2020-01-09

Similar Documents

Publication Publication Date Title
KR102162129B9 (ko) 항-갈렉틴-9 항체 및 이의 용도
BR112015032224A2 (pt) anticorpos anti-fcrh5
DK3668512T3 (da) Pyruvatkinasemodulatorer og anvendelse deraf
MA50404A (fr) Protéines immunomodulatrices à variants de ligand de icos variant, compositions et méthodes associées
ES2973572T3 (es) Formulaciones de anticuerpos humanos anti-RANKL, y métodos de uso de los mismos
DK3514153T3 (da) Pyrimidinforbindelse og farmaceutisk anvendelse deraf
DK3496654T3 (da) Dynamisk tandbuekort
DK3137051T3 (da) Oral care composition comprising cuttlefish bone powder and uses thereof
DK3625484T3 (da) Rotationstætningsindretning og rotationstætning med tilbageføringsfunktion
DK3427717T3 (da) Konstrueret gel-fyldt kosmetisk maske
DK3641719T3 (da) Dental klæber
DE112018000374A5 (de) Handprothesengrundkörper
DK3354169T3 (da) Skønhedsspejl med farefri desinfektion
DE112020000395A5 (de) Förderverfahren und Fördervorrichtung
UY4611S (es) Configuración aplicada en implante dental
UY4713S (es) Configuración aplicada en cuchara lacre
MA49882A (fr) Combinaison entre trifluridine/ chlorhydrate de tipiracil, complexe de platine anti-tumoral et modulateur de point de contrôle immunitaire
DK3430087T3 (da) Hudklæbende siliconegel
MA51009A (fr) Composition de soins buccaux
DK3649080T3 (da) Ammoniakfremstillingsfremgangsmåde
DK3788187T3 (da) Kombineret elektrorotations- og mikroekstruderingsanordning
IT201700076961A1 (it) Dispositivo protesico dentale e relativo componente di collegamento intermedio
DK3357517T3 (da) Klæbemiddelsammensætning samt fastgørelseselement til menneskehud
DE112017002772A5 (de) Blattfederanordnung und Blattfeder
DK3390355T3 (da) Benzensulfonyl-asymmetriske urea og medicinske anvendelser deraf